CymaBay Therapeutics Inc (NASDAQ:CBAY)
| 9.45 Delayed Data As of Jun 06 |  -0.15 / -1.56%Today’s Change | 1.81 Today|||52-Week Range 11.22 | +50.72% Year-to-Date |
Latest CBAY News | Press Releases
No recent news for CymaBay Therapeutics Inc.
Today’s Trading
| Previous close | 9.60 |
| Today’s open | 9.60 |
| Day’s range | 9.42 - 9.62 |
| Volume | 79,814 |
| Average volume (3 months) | 1,560,572 |
| Market cap | $920.5M |
Data as of 3:59pm ET, 06/06/2023
Growth & Valuation
| Earnings growth (last year) | +4.69% |
| Earnings growth (this year) | +15.35% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 22.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HLFHerbalife Ltd | +0.42 | +3.55% |
| NUSNU Skin Enterprises ... | +0.88 | +2.62% |
| DITAMCON Distributing C... | +5.85 | +3.05% |
| ---- |
Data as of 3:59pm ET, 06/06/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$106.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
